Strong Revenue Growth:
Historical revenue acceleration is underscored by a top-50 placement on the 2026 Inc. 5000 and reported 2025 profitability, pointing to substantial commercial momentum.
Investor Backing & Capital Strength:
Successive venture rounds culminating in a $100 million Series C and approximately $215 million total funding indicate deep capital support for expansion into AI, provider capacity, and broader metabolic care.
Market Expansion:
Reported nationwide availability includes access to over 200 million covered lives, a network exceeding 10,000 registered dietitians, and more than 500,000 patients served, signaling rapid scaling of distribution and capacity.
